Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Associations between cytokine levels and CYP3A4 phenotype in patients with rheumatoid arthritis.

Wollmann BM, Syversen SW, Vistnes M, Lie E, Mehus LL, Molden E.

Drug Metab Dispos. 2018 Jul 10. pii: dmd.118.082065. doi: 10.1124/dmd.118.082065. [Epub ahead of print]

PMID:
29991576
2.

Comparison of CYP3A4-Inducing Capacity of Enzyme-Inducing Antiepileptic Drugs Using 4β-Hydroxycholesterol as Biomarker.

Hole K, Wollmann BM, Nguyen C, Haslemo T, Molden E.

Ther Drug Monit. 2018 Aug;40(4):463-468. doi: 10.1097/FTD.0000000000000518.

PMID:
29649093
3.

4β-Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State.

Wollmann BM, Syversen SW, Lie E, Gjestad C, Mehus LL, Olsen IC, Molden E.

Clin Transl Sci. 2017 Jan;10(1):42-49. doi: 10.1111/cts.12431. Epub 2016 Nov 5.

Supplemental Content

Loading ...
Support Center